Global Prefilled Syringes Market to 2028 – Collaborations and Investments to Open an Array of Opportunities for the Market to Flourish – ResearchAndMarkets.com

Global Prefilled Syringes Market to 2028 – Collaborations and Investments to Open an Array of Opportunities for the Market to Flourish – ResearchAndMarkets.com




Global Prefilled Syringes Market to 2028 – Collaborations and Investments to Open an Array of Opportunities for the Market to Flourish – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Prefilled Syringes Global Market – Forecast To 2028” report has been added to ResearchAndMarkets.com’s offering.

The prefilled syringes global market is expected to grow at a high single digit CAGR to reach $10,273.8 million by 2028.

The prefilled syringes global market is categorized into various market segments based on the material, design, closure system, application, product, usability, molecule type, route of administration and geography.

The prefilled syringes global market based on material is segmented into glass based prefilled syringes and polymer based prefilled syringes. Among these, glass based prefilled syringes segment commanded the largest revenue in 2021 and is expected to grow at a high single digit CAGR from 2021 to 2028. Polymer based prefilled syringes segment is the fastest emerging segment and is expected to grow at a double digit CAGR from 2021 to 2028.

The prefilled syringes global market based on design is grouped into single chamber prefilled syringes and dual chamber prefilled syringes. Among these, single chamber prefilled syringes segment commanded the largest revenue in 2021 and is expected to grow at a high single digit CAGR from 2021 to 2028. Dual chamber prefilled syringes segment is the fastest emerging segment and is expected to grow at a double digit CAGR during the forecasted period.

The prefilled syringes global market based on closure system is classified into staked needle prefilled syringes, luer lock prefilled syringes and non-luer lock prefilled syringes. Among these, staked needle prefilled syringes segment commanded the largest revenue in 2021 and is also the fastest growing segment that is expected to grow at a high single digit CAGR from 2021 to 2028.

The prefilled syringes global market based on application is categorized into heparin prefilled syringes, vaccines prefilled syringes, therapeutic drugs prefilled syringes, diluents prefilled syringes, surgical application prefilled syringes, hyaluronic acid prefilled syringes and other prefilled syringes applications (other anticoagulant prefilled syringes, saline flush prefilled syringes and contrast imaging agents prefilled syringes). Among these, heparin prefilled syringes segment commanded the largest revenue in 2021 and is expected to grow at a mid-single digit CAGR from 2021 to 2028. Therapeutic drugs prefilled syringes segment is the fastest emerging segment and is expected to grow at a low teen CAGR from 2021 to 2028.

The prefilled syringes global market based on product is divided into complete prefilled syringes, consumables (needles) and accessory devices (autoinjectors, syringe pumps, wearable injectors). Among these, complete prefilled syringes segment accounted for the largest revenue in 2021 and is expected to grow at a high single digit CAGR from 2021 to 2028. Accessory devices segment is the fastest emerging segment and is expected to grow at a high single digit CAGR from 2021 to 2028. Complete prefilled syringes segment based on product type is further segregated into conventional prefilled syringes and safety prefilled syringes. Among these, safety prefilled syringes segment accounted for the largest revenue in 2021 and is also the fastest growing segment that is expected to grow at a high single digit CAGR from 2021 to 2028.

Market Dynamics

Drivers and Opportunities

  • Increasing Popularity of Prefilled Syringes Among Patients and Healthcare Professionals
  • Increasing Inclination of Pharmaceutical Companies Towards Prefilled Syringes for Injectable Drug Product Cost-Savings and Brand Differentiation
  • Preferential Adoption of Prefilled Syringes for the Delivery of Biologics
  • Emergence of Technologically Advanced Products
  • Escalating Prevalence of Chronic and Infectious Diseases and Allergies
  • Increasing Regulatory Approvals of Prefilled Syringes
  • Collaborations and Investments to Open An Array of Opportunities for the Market to Flourish

Restraints and Threats

  • Technical Challenges Associated With Manufacturing Process of Prefillable Syringes
  • Increasing Concerns About the Interaction of Prefillable Syringe Components With Drug Products
  • Availability of Less Expensive and Non-Invasive Medication Alternatives
  • Stringent International Standards and Regulatory Guidelines to Followed by Prefillable Syringe Manufacturers
  • Threat of Recalls of Prefilled Syringes

Companies Mentioned

  • Aguettant Ltd.
  • ApiJect Systems Corp.
  • Arte Corporation
  • Becton, Dickinson And Company
  • Biocorp
  • Congruence Medical Solutions LLC
  • Credence MedSystems Inc.
  • Dali Medical Devices
  • Elcam Medical
  • Gerresheimer AG
  • Hamilton Medical
  • Injecto A/S
  • Jinan Youlyy Industrial Co., Ltd.
  • MEDInstill LLC (Intact Solutions)
  • Merit Medical Systems Inc.
  • Molex (Philips-Medisize)
  • Nemera
  • Nemoto Kyorindo Co., Ltd.
  • Nipro Corporation
  • Owen Mumford LTD
  • Plas-Tech Engineering
  • Recipharm (Bespak)
  • Repro Med Systems, Inc (KORU medical systems)
  • Retractable Technologies, Inc.
  • Roselabs Biosciences Pvt Ltd.
  • Schott AG
  • Shandong Weigao Group Medical Polymer Company Limited
  • Shanghai Kohope Medical Devices Co., Ltd.
  • SHL Medical
  • SMC Ltd.
  • Stevanato Group S.p.A
  • Taisei Kako Co., Ltd.
  • Terumo Corporation
  • Transcoject GmbH
  • Tribofilm Research Inc.
  • Vetter Pharma International GmbH
  • Ypsomed Holding AG

For more information about this report visit https://www.researchandmarkets.com/r/jmw1tw

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900